Ropivacaine recalls

The FDA has published 5 recalls involving Ropivacaine since 2018. The latest was reported on 29 Jul 2026. Most were for particulate matter. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls5since 2018

Last 12 months1reported

Class I120% of total

Ongoing4latest 29 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 1 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 1Jul 0 0

Severity split

Class I 1 20%Class II 4 80%Class III 0 0%

Why ropivacaine is recalled

Companies

Brands

Ropivacaine Hydrochloride120%
Naropin120%

By year

2026120%
2025120%
2023240%
2018120%

Ongoing ropivacaine recalls

4 active

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Naropin (ropivacaine hydrochloride Injection, USP) recalledNaropin	Fresenius Kabi USA	Particulate Matter	Nationwide
14 May 2025Drug	CLASS I	Ropivacaine Hydrochloride Injection, USP, 5%, 500 mg per (5mg/mL) recalledRopivacaine Hydrochloride	Amneal Pharmaceuticals	Particulate Matter	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 5%, 150mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 2%, 200mg/ (2 mg/mL) Vial recalled	Akorn	Potency & Assay	Nationwide

All ropivacaine recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Naropin (ropivacaine hydrochloride Injection, USP) recalledNaropin	Fresenius Kabi USA	Particulate Matter	Nationwide
14 May 2025Drug	CLASS I	Ropivacaine Hydrochloride Injection, USP, 5%, 500 mg per (5mg/mL) recalledRopivacaine Hydrochloride	Amneal Pharmaceuticals	Particulate Matter	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 5%, 150mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Ropivacaine Hydrochloride Injection USP, 2%, 200mg/ (2 mg/mL) Vial recalled	Akorn	Potency & Assay	Nationwide
28 Feb 2018Drug	CLASS II	Ropivacaine HCl Injection in all strengths, all doses recalled	Pharmedium Services	Sterility	Nationwide

Should you stop taking Ropivacaine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.